Credit Trends: The Media And Entertainment Sector Shows High Downgrade Potential | S&P Global Ratings
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva's volatility and Pfizer's plant upgrade a threat to rating, S&P
Credit Rating Process | A Complete Beginner's Guide
Teva Raises $2.1 Billion in Debt Tender Offer | Ctech
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Reports Third Quarter 2021 Financial Results
Teva to axe 14,000 jobs despite uproar in Israel | Financial Times
S&P Global Ratings downgrades Local Currency LT credit rating of Teva Pharmaceutical Industries to "BB-"; outlook stable
Moody's Downgrades Teva Bond Rating to “Junk” | Ctech
Credit Trends: Downgrade Potential Rises To All-Time High On Sharp, Deep Economic Slowdown | S&P Global Ratings
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption (NYSE: TEVA) | Seeking Alpha
Teva woes deepen as Fitch cuts credit rating to junk | The Times of Israel
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva's rating cut to junk, Two Lupin facilities receive FDA warning letters | Radio Compass Blog
CSRWire - Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets
Moody's upgrades Teva's rating outlook - גלובס
Credit Rating Process | A Complete Beginner's Guide
Teva's stock and bonds walloped after Fitch downgrade to junk - MarketWatch
Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024 | Business Wire
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire
Teva Pharmaceuticals USA Inc - ZIP 24551, NAICS 325412
Why Teva's Stock Could Crash Another 50% | BioSpace
